Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease

Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases

(2018) Tayyeba K. Ali et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation

(2018) Yoshihiro Inamoto et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Lifitegrast for the treatment of dry eye disease in adults

(2017) Eric D. Donnenfeld et al.   EXPERT OPINION ON PHARMACOTHERAPY

Lifitegrast for the Treatment of Dry Eye Disease

(2017) Edward J. Holland et al.   OPHTHALMOLOGY

A Review of Ocular Graft-Versus-Host Disease

(2017) Saleha Z. Munir et al.   OPTOMETRY AND VISION SCIENCE

A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease

(2016) Francesco Zallio et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease

(2016) Victor L. Perez et al.   Ocular Surface

Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies

(2015) Eduardo Anitua et al.   ACTA OPHTHALMOLOGICA

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

(2015) Stephanie J. Lee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

(2015) Madan H. Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD

(2015) Jay Ching Chieh Wang et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

(2015) L. M. Curtis et al.   HAEMATOLOGICA

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease

(2015) Joseph Tauber et al.   OPHTHALMOLOGY

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

(2015) L. M. Curtis et al.   HAEMATOLOGICA

Grading criteria for chronic ocular graft-versus-host disease: Comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score

(2014) Yukako Tatematsu et al.   Scientific Reports

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

(2013) T Ruutu et al.   BONE MARROW TRANSPLANTATION

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease

(2013) John D. Sheppard et al.   OPHTHALMOLOGY

International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)

(2013) Yoko Ogawa et al.   Scientific Reports

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye

(2012) Charles P. Semba et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye

(2012) Min Zhong et al.   ACS Medicinal Chemistry Letters

Tear physiology in dry eye associated with chronic GVHD

(2011) S Khanal et al.   BONE MARROW TRANSPLANTATION

Validation of Measurement Scales in Ocular Graft-versus-Host Disease

(2011) Yoshihiro Inamoto et al.   OPHTHALMOLOGY

Immune Processes and Pathogenic Fibrosis in Ocular Chronic Graft-Versus-Host Disease and Clinical Manifestations after Allogeneic Hematopoietic Stem Cell Transplantation

(2010) Yoko Ogawa et al.   CORNEA

Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation

(2010) Arnaud C Westeneng et al.   CORNEA

Current insights into ocular graft-versus-host disease

(2010) Anjo Riemens et al.   CURRENT OPINION IN OPHTHALMOLOGY

Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation

(2009) Yang Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Defining the Intensity of Conditioning Regimens: Working Definitions

(2009) Andrea Bacigalupo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye

(2009) Y Wang et al.   BONE MARROW TRANSPLANTATION

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET